ARCHIVES

Mesothelioma Survival, QOL Improved With Alimta, Platinol

This article is from The Cancer Letter archive.

Vol. 26 No. 3 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

NCCR Calls For 15% Increase In NIH Budget, “Investment Priority”

February 11, 1994

NCI-Approved Clinical Trials

December 30, 2005

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

Breast Density As Important As Age In Determining Risk

September 29, 2006

Program Announcement For Clinical Research

February 29, 1980